Erschienen in:
20.12.2023 | Commentary
Looking at the rim in multiple sclerosis: new MRI-based biomarkers may open our eyes to the disease’s evolution
verfasst von:
Jean-Christophe Brisset, François Cotton
Erschienen in:
European Radiology
|
Ausgabe 2/2024
Einloggen, um Zugang zu erhalten
Excerpt
The identification of new prognostic biomarkers for progressive multiple sclerosis (MS) is crucial for the development of new therapeutic interventions targeting this phase of the disease [
1]. The study entitled “Deeply 3D-T1-TFE hypointense voxels are characteristic of phase-rim lesions in multiple sclerosis” in this current issue of
European Radiology investigates the use of a derived metric from 3D T1-weighted turbo field echo (3DT1TFE) MRI to identify phase-rim lesions (PRLs), which have been proposed as possible markers of progressive MS [
2]. …